These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 26117456

  • 1. Keap1-Nrf2 signalling in pancreatic cancer.
    Hayes AJ, Skouras C, Haugk B, Charnley RM.
    Int J Biochem Cell Biol; 2015 Aug; 65():288-99. PubMed ID: 26117456
    [Abstract] [Full Text] [Related]

  • 2. MBD1 is an Epigenetic Regulator of KEAP1 in Pancreatic Cancer.
    Zhang B, Xu J, Li C, Shi S, Ji S, Xu W, Liu J, Jin K, Liang D, Liang C, Liu L, Liu C, Qin Y, Yu X.
    Curr Mol Med; 2016 Aug; 16(4):404-11. PubMed ID: 26980696
    [Abstract] [Full Text] [Related]

  • 3. The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic.
    O'Connell MA, Hayes JD.
    Biochem Soc Trans; 2015 Aug; 43(4):687-9. PubMed ID: 26551713
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma.
    Hamada S, Shimosegawa T, Taguchi K, Nabeshima T, Yamamoto M, Masamune A.
    Am J Physiol Gastrointest Liver Physiol; 2018 Jan 01; 314(1):G65-G74. PubMed ID: 28971839
    [Abstract] [Full Text] [Related]

  • 5. Modulation of Nrf2/Keap1 system by Wasabi 6-methylthiohexyl isothiocyanate in ARE-mediated NQO1 expression.
    Korenori Y, Tanigawa S, Kumamoto T, Qin S, Daikoku Y, Miyamori K, Nagai M, Hou DX.
    Mol Nutr Food Res; 2013 May 01; 57(5):854-64. PubMed ID: 23390006
    [Abstract] [Full Text] [Related]

  • 6. Nrf2-Keap1 antioxidant defense and cell survival signaling are upregulated by 17β-estradiol in homocysteine-treated dopaminergic SH-SY5Y cells.
    Chen CS, Tseng YT, Hsu YY, Lo YC.
    Neuroendocrinology; 2013 May 01; 97(3):232-41. PubMed ID: 22948038
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of the Keap1-Nrf2 pathway in cancer.
    Leinonen HM, Kansanen E, Pölönen P, Heinäniemi M, Levonen AL.
    Adv Cancer Res; 2014 May 01; 122():281-320. PubMed ID: 24974185
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tetrachlorobenzoquinone activates Nrf2 signaling by Keap1 cross-linking and ubiquitin translocation but not Keap1-Cullin3 complex dissociation.
    Su C, Zhang P, Song X, Shi Q, Fu J, Xia X, Bai H, Hu L, Xu D, Song E, Song Y.
    Chem Res Toxicol; 2015 Apr 20; 28(4):765-74. PubMed ID: 25742418
    [Abstract] [Full Text] [Related]

  • 12. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.
    DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, Mangal D, Yu KH, Yeo CJ, Calhoun ES, Scrimieri F, Winter JM, Hruban RH, Iacobuzio-Donahue C, Kern SE, Blair IA, Tuveson DA.
    Nature; 2011 Jul 06; 475(7354):106-9. PubMed ID: 21734707
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis.
    Abu-Alainin W, Gana T, Liloglou T, Olayanju A, Barrera LN, Ferguson R, Campbell F, Andrews T, Goldring C, Kitteringham N, Park BK, Nedjadi T, Schmid MC, Slupsky JR, Greenhalf W, Neoptolemos JP, Costello E.
    J Pathol; 2016 Feb 06; 238(3):423-33. PubMed ID: 26497117
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T, Ishii Y, Homma S, Morishima Y, Kurishima K, Itoh K, Yamamoto M, Minami Y, Noguchi M, Hizawa N.
    Oncogene; 2012 Nov 08; 31(45):4768-77. PubMed ID: 22249257
    [Abstract] [Full Text] [Related]

  • 19. Oxaliplatin activates the Keap1/Nrf2 antioxidant system conferring protection against the cytotoxicity of anticancer drugs.
    Wang XJ, Li Y, Luo L, Wang H, Chi Z, Xin A, Li X, Wu J, Tang X.
    Free Radic Biol Med; 2014 May 08; 70():68-77. PubMed ID: 24556415
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.